An open-label, uncontrolled long-term safety study of CP-464 005 (inhaled insulin) in Japanese patients with type 1 or type 2 diabetes.

Trial Profile

An open-label, uncontrolled long-term safety study of CP-464 005 (inhaled insulin) in Japanese patients with type 1 or type 2 diabetes.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 16 Oct 2009

At a glance

  • Drugs Insulin (Primary)
  • Indications Diabetes mellitus
  • Focus Adverse reactions
  • Sponsors Pfizer
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 16 Oct 2009 Last checked against ClinicalTrials.gov record.
    • 28 Aug 2008 Planned end date changed from 1 Jan 2009 to 1 Jul 2008 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top